/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Citius Oncology Inc Share Price Today: Live Updates & Key Insights

Citius Oncology Inc share price today is $0.567, up -2.77%. The stock opened at $0.58495 against the previous close of $0.5782, with an intraday high of $0.58495 and low of $0.541.

Citius Oncology Inc Share Price Chart

style
pb-0

Citius Oncology Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Citius Oncology Inc Share Price Performance

$0.567 -0.0277(-2.77%) CTOR at 27 Jul 2026 02:34 PM Drug Manufacturers - Specialty & Generic
Lowest Today 0.541
Highest Today 0.58495
Today’s Open 0.58495
Prev. Close 0.5782
52 Week High 2.37
52 Week Low 0.49
Day’s Range: Low 0.541 High 0.58495
52-Week Range: Low 0.49 High 2.37
1 day return -
1 Week return -13.7
1 month return -12.73
3 month return -37.56
6 month return -50.35
1 year return -71.37
3 year return -
5 year return -
10 year return -

Citius Oncology Inc Institutional Holdings

Armistice Capital, LLC 9.88

Bank of America Corp 4.12

Vanguard Group Inc 0.64

Vanguard Capital Management, LLC 0.58

Vanguard Total Stock Mkt Idx Inv 0.40

Geode Capital Management, LLC 0.28

Vanguard Institutional Extnd Mkt Idx Tr 0.19

Vanguard Fiduciary Trust Co 0.13

Fidelity Extended Market Index 0.12

IFP Advisors, LLC 0.12

Fidelity Nasdaq Composite Index 0.06

BlackRock Inc 0.05

Northern Trust Corp 0.05

State Street Corp 0.05

UBS Group AG 0.04

Spartan Extended Market Index Pool F 0.03

Fidelity Total Market Index 0.03

Fidelity Series Total Market Index 0.03

Northern Trust Extended Eq Market Idx 0.03

NT Ext Equity Mkt Index Fund - Lending 0.03

NT Ext Equity Mkt Index Fund - NL 0.02

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

Vanguard Instl Ttl Stck Mkt Index Trust 0.01

Spartan Total Market Index Pool G 0.01

Arkadios Wealth Advisors 0.01

Advisor Group Holdings, Inc. 0.01

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.01

1290 VT Micro Cap K 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Index Fund - Ld 0.00

Royal Bank of Canada 0.00

Wellington CIF Micro Cap Equity 0.00

Caitong International Asset Management Co., Limited. 0.00

Citadel Advisors Llc 0.00

Morgan Stanley - Brokerage Accounts 0.00

Omers Administration Corp 0.00

Renaissance Technologies Corp 0.00

Tower Research Capital LLC 0.00

Citius Oncology Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Citius Oncology Inc Fundamentals

Market Cap 53.76 M

PB Ratio 1.5536

PE Ratio 0.0

Enterprise Value 54.46 M

Total Assets 100.94 M

Volume 55822

Citius Oncology Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M

Annual Profit FY25:null 0.0M, FY24:null 0.0M

Annual Net worth FY25:-24761369 -24.8M, FY24:-21148747 -21.1M

Quarterly Revenue Q1/2026:1667298 1.7M, Q4/2025:3944111 3.9M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M

Quarterly Profit Q1/2026:1338420 1.3M, Q4/2025:3154903 3.2M, Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M

Quarterly Net worth Q1/2026:-26609695 -26.6M, Q4/2025:-5534069 -5.5M, Q3/2025:-4996656 -5.0M, Q2/2025:-5369956 -5.4M, Q1/2025:-7735552 -7.7M

About Citius Oncology Inc & investment objective

Company Information Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.

Organisation Drug Manufacturers - Specialty & Generic

Employees 0

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Leonard L. Mazur

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Citius Oncology Inc FAQs

What is the share price of Citius Oncology Inc today?

The current share price of Citius Oncology Inc is $0.567.

Can I buy Citius Oncology Inc shares in India?

Yes, Indian investors can buy Citius Oncology Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Citius Oncology Inc shares in India?

You can easily invest in Citius Oncology Inc shares from India by:

Can I buy fractional shares of Citius Oncology Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Citius Oncology Inc?

Citius Oncology Inc has a market cap of $53.76 M.

In which sector does Citius Oncology Inc belong?

Citius Oncology Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Citius Oncology Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Citius Oncology Inc?

The PE ratio of Citius Oncology Inc is N/A and the PB ratio is 1.55.